ADMA Biologics (ADMA) Hit With Federal Securities Lawsuit Over Revenue Inflation Allegations

Insider Trading
ADMA Biologics faces a federal securities lawsuit alleging revenue inflation through channel stuffing and concealed distribution relationships.

Summary

ADMA Biologics, Inc. (NASDAQ:ADMA) is currently navigating a complex landscape of analyst optimism and significant legal challenges. On June 10, 2026, Raymond James analyst Ryan Deschner initiated coverage with an

(Source:Insider Trading)

The News International

Canadians who bought beef products may qualify for class action payout

Fox Business

Costco hit with lawsuit alleging protein powder sold in stores contains 'dangerous' levels of lead, arsenic

SooToday

$8-million settlement proposed in national beef price-fixing class-action

The News International

Costco faces class action over alleged heavy metals in Orgain protein supplements

scanx.trade

GRAL investors face August 4 deadline in Grail securities lawsuit

Google News

State AGs finalizing antitrust lawsuit over Paramount–Warner Bros. Discovery merger

Chicago Suntimes

Cash App parent company agrees to $45 million settlement with Illinois, 44 other states - Chicago Sun-Times

Headtopics

Mavericks owners froze Mark Cuban out of business opportunities in proposed arena move, lawsuit claims

The Economic Times

CBDT exempts NCCL settlement fund from tax

Livemint

Microsoft's $7.3 billion AI data centre sued over ‘freight train-like’ non-stop noise

Hoodline

Wegmans Faces Landlord Lawsuit Over $479K at Fenton

Https://www.kswo.com

Drummond files lawsuit against Allstate Insurance

Patch

Fort Worth Announces Nuisance Abatement Lawsuit Against Central Motel

Cfotech Australia

SS&C to add digital cash settlement for tokenised funds

Headtopics

Anchorage Secures $191.3 Million Federal Settlement for Port of Alaska Modernization